PME Lunch Symposium (Non-CME)
A Treatment Option for Patients With HFrEF Following a Worsening HF Event
Sponsored by Merck Sharp and Dohme Corp.
Matthew J. Budoff, MD
Friday, April 8, 2022
12:15 PM - 1:15 PM
Room: Trailblazers Ballroom
After completing this activity, the participant should be better able to:
- Highlight the burden of HFH in patients with HFrEF.
- Review a treatment option for reducing the risk of HFH and CV death in patients with HFrEF.
About the Speaker:
Matthew J. Budoff, MD, FACC, FAHA is the Endowed Chair of Preventive Cardiology at the Lundquist Institute at Harbor-UCLA Medical Center and a Professor of Medicine at the David Geffen School of Medicine at UCLA. Dr. Budoff earned his MD from the George Washington University School of Medicine in Washington, DC. He completed both; his residency and his fellowship in cardiology at Harbor-UCLA Medical Center in Torrance, CA. Dr. Budoff is board certified in Cardiovascular Disease and Cardiovascular Computed Tomography. He is a Fellow of the American Heart Association, the American College of Cardiology, the Society of Cardiac Angiography and Intervention and the Society of Cardiovascular Computed Tomography. Dr. Budoff is a widely published researcher and international lecturer who holds several US patents. He sits on the Editorial Boards for the Journal of Invasive Cardiology, Clinical Cardiology, the International Journal of Cardiodiabetes and others.